Furthermore, DLL3 expression is more abundant in neoplastic cells, especially in small-cell lung cancer and other neuroendocrine neoplasms, as opposed to healthy cells where they do not exert any expression except for in the testis and central nervous system. Here, DLL3 is linked to neuroendocrine neoplasm.